Diagnosing cardiac amyloidosis: A wealth of new possibilities with nuclear cardiac imaging

[1] Falk RH(2016)AL (light-chain) cardiac amyloidosis: A review of diagnosis and therapy J Am Coll Cardiol 68 1323-1341

[2] Alexander KM(2019)State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis J Nucl Cardiol. 26 158-173

[3] Liao R(1982)Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis Am Heart J 103 468-473

[4] Dorbala S(1987)Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis Arch Intern Med 147 1039-1044

[5] Singh V(2005)Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy J Am Coll Cardiol 46 1076-1084

[6] Falk R(2013)(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses Circ Cardiovasc Imaging 6 195-201

[7] Di Carli MF(2016)Nonbiopsy diagnosis of cardiac transthyretin amyloidosis Circulation 133 2404-2412

[8] Kijewski M(2019)Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis J Nucl Cardiol 43 e89-e92

[9] Rapezzi C(2018)Discordant findings on 18F-NaF and 99mTc-HDP Bone scans in a patient with ATTR cardiac amyloidosis Clin Nucl Med 20 163-178

[10] Dorbala S(2015)Natural history and therapy of TTR-cardiac amyloidosis: Emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs Heart Fail Rev 98 1442-1448

[1] Falk RH(2016)AL (light-chain) cardiac amyloidosis: A review of diagnosis and therapy J Am Coll Cardiol 68 1323-1341

[2] Alexander KM(2019)State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis J Nucl Cardiol. 26 158-173

[3] Liao R(1982)Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis Am Heart J 103 468-473

[4] Dorbala S(1987)Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis Arch Intern Med 147 1039-1044

[5] Singh V(2005)Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy J Am Coll Cardiol 46 1076-1084

[6] Falk R(2013)(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses Circ Cardiovasc Imaging 6 195-201

[7] Di Carli MF(2016)Nonbiopsy diagnosis of cardiac transthyretin amyloidosis Circulation 133 2404-2412

[8] Kijewski M(2019)Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis J Nucl Cardiol 43 e89-e92

[9] Rapezzi C(2018)Discordant findings on 18F-NaF and 99mTc-HDP Bone scans in a patient with ATTR cardiac amyloidosis Clin Nucl Med 20 163-178

[10] Dorbala S(2015)Natural history and therapy of TTR-cardiac amyloidosis: Emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs Heart Fail Rev 98 1442-1448